Delivery Order SPE2DB25D3109-SPE2DB25FPKDV

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,664.55 firm fixed-price contract is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product, with a completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,578.55 firm fixed-price delivery order is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,713.06 firm-fixed-price delivery order is for the supply of DIFICID 200 mg tablets. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $58,715.10 firm fixed-price delivery order contract is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of July 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,595.72 firm fixed-price contract is for the supply of DIFICID 200 MG TABLET 20S, with a performance period ending on May 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,057.16 firm fixed-price delivery order is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The award has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,178.68 and is a Firm Fixed Price Delivery Order with an ultimate completion date of December 27, 2024. The contract is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. Amerisourcebergen is the prime contractor on this award, and there is no indication of...
This federal contract award, valued at $12,201.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,415.14 firm fixed-price delivery order is for the product "DIFICID 200 MG TABLET 20S" and has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award is a delivery order worth $7,243.13 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) and is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with...
  • SPE2DB25D3109
    Indefinite Delivery Contract
  • SPE2DB25D3109-SPE2DB25FPKDV
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $10,984.75, and covers the supply of DIFICID 200 MG TABLET 20S. The contract has an ultimate completion date of April 1, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is a task order under this larger IDC. There is no set-aside designation for this contract.

Generated 6/30/25, 10:42 AM